What’s Trending?

Pharma companies Pfizer, Merck and Johnson & Johnson are dodging billions of dollars of tax payments annually, an Oxfam report concluded. [...]
Thu, Sep 20, 2018
Source FiercePharma
Allergan already has a laundry list of celebrities backing its Alzheimer's awareness push, but that didn't stop it from adding one more this week. [...]
Thu, Sep 20, 2018
Source FiercePharma
Hoping Asia could contribute about $1.5 billion in medical aesthetics revenue growth by 2025, Allergan has decided to place its first Medical Aesthetics Innovation Center in Chengdu, China, and expects to train 3,000 practitioners there each year. [...]
Thu, Sep 20, 2018
Source FiercePharma
AbbVie and its investors have been fretting over the potential impact of biosimilar competition to Humira—the world's top-selling drug, with more than $18 billion a year in sales—and now they have another contender to worry about. Mylan and Fujifilm's Hulio is the fifth Humira biosimilar to win marketing approval in [...]
Thu, Sep 20, 2018
Source FiercePharma
Cancer Research UK is partnering with European cancer research charities AIRC (Associazione Italiana per la Ricerca sul Cancro) and FC AECC (Asociación Española Contra el Cáncer) to invest around £30 million in six international collaborations aiming to accelerate progress in translational research. [...]
Thu, Sep 20, 2018
Source PharmaTimes
US regulators have turned down Pharming's application to expand the approved uses of Ruconest to include prophylaxis in patients with hereditary angioedema (HAE). [...]
Thu, Sep 20, 2018
Source PharmaTimes
The European Commission has approved Mylan and Fujifilm Kyowa Kirin Biologics' Humira biosimiar Hulio. [...]
Thu, Sep 20, 2018
Source PharmaTimes
A Phase III study assessing Astellas' roxadustat in patients with chronic kidney disease (CKD) and anaemia who are not receiving dialysis has met its key endpoints. [...]
Thu, Sep 20, 2018
Source PharmaTimes
Novo Nordisk
Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious chronic diseases. To enable increased investment in transformational biological and technological innovation within both core and new therapy areas, approximately 400 employees will be laid off from [...]
Wed, Sep 19, 2018
Source WorldPharmaNews
Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial published online Sept. 16 in three papers in the New England Journal of Medicine. The large clinical trial, which began in 2010, aimed [...]
Tue, Sep 18, 2018
Source WorldPharmaNews
Amgen
Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest global survey to date investigating perceptions of Alzheimer's disease. Findings show that most adults (62 percent) are worried [...]
Tue, Sep 18, 2018
Source WorldPharmaNews
A table in a recently published paper tells the story of 30 families who have, sometimes after years of searching, finally received an answer about the condition that has plagued one or more family members. The Brigham Genomic Medicine (BGM) program, an integrated, multi-disciplinary clinical and research program, brings together [...]
Mon, Sep 17, 2018
Source WorldPharmaNews
Sponsors submitting pediatric study plans should consider whether a product affects adults and children similarly when choosing an approach, the FDA says. [...]
Fri, Jan 16, 2015
Source FDANews